The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
HCW Biologics Inc (NASDAQ: HCWB) closed the day trading at $0.40 down -2.44% from the previous closing price of $0.41. In other words, the price has decreased by -$2.44 from its previous closing price. On the day, 0.17 million shares were traded. HCWB stock price reached its highest trading level at $0.42 during the session, while it also had its lowest trading level at $0.3801.
Ratios:
For a better understanding of HCWB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.07 and its Current Ratio is at 0.07.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCWB now has a Market Capitalization of 17816160 and an Enterprise Value of 20006178. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.32. Its current Enterprise Value per Revenue stands at 5.1 whereas that against EBITDA is -0.547.
Stock Price History:
The Beta on a monthly basis for HCWB is 0.88, which has changed by -0.6363636 over the last 52 weeks, in comparison to a change of 0.23806548 over the same period for the S&P500. Over the past 52 weeks, HCWB has reached a high of $2.52, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is -14.95%, while the 200-Day Moving Average is calculated to be -48.40%.
Shares Statistics:
Over the past 3-months, HCWB traded about 9.41M shares per day on average, while over the past 10 days, HCWB traded about 277220 shares per day. A total of 37.82M shares are outstanding, with a floating share count of 19.75M. Insiders hold about 47.77% of the company’s shares, while institutions hold 8.10% stake in the company. Shares short for HCWB as of 1730332800 were 8092 with a Short Ratio of 0.02, compared to 1727654400 on 28052. Therefore, it implies a Short% of Shares Outstanding of 8092 and a Short% of Float of 0.04.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
1 analysts predict $7M in revenue for the current quarter. It ranges from a high estimate of $7M to a low estimate of $7M. As of the current estimate, HCW Biologics Inc’s year-ago sales were $1.32M
A total of 1 analysts have provided revenue estimates for HCWB’s current fiscal year. The highest revenue estimate was $9.17M, while the lowest revenue estimate was $9.17M, resulting in an average revenue estimate of $9.17M. In the same quarter a year ago, actual revenue was $2.84M
